Abvc executes cooperation agreement for strategic investments

Fremont, ca, aug. 17, 2023 (globe newswire) -- via newmediawire –  abvc biopharma, inc.  (nasdaq: abvc) ("company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, neurology, and ophthalmology, announced today that it had entered into a cooperation agreement to exchange a 20% ownership stake in real estate property of zhonghui united technology (chengdu) group co., ltd. (“中汇联和科技(成都)集团有限公司”) and its affiliated enterprises (“zhonghui”).
ABVC Ratings Summary
ABVC Quant Ranking